MLKL promotes shikonin-induced necroptosis in glioma cells by promoting chromatin lysis, and shikonin induces positive feedback between MLKL and its upstream signals RIP1 and RIP3, thereby promoting the death of glioma including GBM cells (34). Here, RIPK3 is linked to central nervous system cancer.